secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearSign Technologies Corp (CLIR)
CIK:        0001434524
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001104659-24-057077
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearSign gets Nasdaq bid price deficiency notice; Maley appointed to committees
--------------------------------------------------------------------------------

- Received Nasdaq notice on May 2, 2024 for closing bid price below $1 for 30 consecutive business days.
- Company has 180-day cure period ending October 29, 2024; must close at $1 for 10 consecutive days.
- If not cured, may seek additional 180-day period with reverse stock split if eligible.
- Independent director David M. Maley appointed to Nominating and Governance Committee and Compensation Committee, effective May 3, 2024.
- Company will monitor bid price and consider options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434524/000110465924057077/0001104659-24-057077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434524/000110465924057077/tm2413489d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-057077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer